Co-sponsored by: Javed Khan

Conference call with the U.S. Food and Drug Administration National Center for Toxicological Research NCTR-ORA Nanotechnology Core Facility. 

Agenda:

Review the current NANOMED SAB activitiy; Potential collaborations between the FDA and our SAB Excutive Commiittee; Current FDA definition on nanoMedicine. 

Location:
Houston, Texas